Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-07 Sale |
2025-03-10 4:43 pm |
VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA |
7,411 | $31.66 | $234,630 | 100,249 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:42 pm |
VERACYTE INC. | VCYT | Febbo Phillip G. Chief Scientific & Med Officer |
8,037 | $33.35 | $268,013 | 82,540 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:41 pm |
VERACYTE INC. | VCYT | Stapley Marc Chief Executive Officer |
52,697 | $33.34 | $1,756,855 | 268,035 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:41 pm |
VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel |
1,142 | $33.69 | $38,476 | 70,308 (Direct) |
View |
| 2025-02-27 Sale |
2025-03-03 4:30 pm |
VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA |
5,746 | $33.84 | $194,445 | 71,420 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-05 4:49 pm |
VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer |
527 | $43.85 | $23,109 | 113,510 (Direct) |
View |
| 2025-01-02 Sale |
2025-01-06 5:16 pm |
VERACYTE INC. | VCYT | EASTHAM KARIN Director |
10,000 | $40.3 | $403,006 | 18,497 (Direct) |
View |
| 2024-12-13 Sale |
2024-12-17 4:31 pm |
VERACYTE INC. | VCYT | Stapley Marc Chief Executive Officer |
5,590 | $43.42 | $242,737 | 307,345 (Direct) |
View |
| 2024-12-04 Sale |
2024-12-06 4:34 pm |
VERACYTE INC. | VCYT | Febbo Phillip G. Chief Scientific & Med Officer |
3,934 | $44.09 | $173,447 | 82,414 (Direct) |
View |
| 2024-12-04 Sale |
2024-12-06 4:34 pm |
VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel |
18,699 | $44.02 | $823,179 | 72,869 (Direct) |
View |
| 2024-12-03 Sale |
2024-12-04 4:59 pm |
VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA |
1,050 | $43.25 | $45,408 | 73,810 (Direct) |
View |
| 2024-12-03 Sale |
2024-12-04 4:59 pm |
VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer |
7,000 | $43.23 | $302,622 | 114,037 (Direct) |
View |
| 2024-12-03 Sale |
2024-12-04 4:59 pm |
VERACYTE INC. | VCYT | Wygant Jonathan VP, Chief Accounting Officer |
956 | $43.36 | $41,452 | 40,270 (Direct) |
View |
| 2024-11-27 Sale |
2024-11-29 2:28 pm |
VERACYTE INC. | VCYT | Wygant Jonathan VP, Chief Accounting Officer |
5,032 | $42.89 | $215,834 | 42,313 (Direct) |
View |
| 2024-11-19 Sale |
2024-11-21 4:36 pm |
VERACYTE INC. | VCYT | EASTHAM KARIN Director |
14,731 | $38.34 | $564,768 | 18,497 (Direct) |
View |
| 2024-11-12 Sale |
2024-11-14 4:35 pm |
VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer |
15,275 | $38.34 | $585,663 | 124,501 (Direct) |
View |
| 2024-11-12 Sale |
2024-11-14 4:35 pm |
VERACYTE INC. | VCYT | EPSTEIN ROBERT S Director |
15,000 | $38.32 | $574,830 | 64,598 (Direct) |
View |
| 2024-09-19 Sale |
2024-09-23 4:23 pm |
VERACYTE INC. | VCYT | JONES EVAN Director |
5,173 | $35.23 | $182,263 | 34,343 (Indirect Direct) |
View |
| 2024-09-04 Sale |
2024-09-06 4:18 pm |
VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA |
5,479 | $29.78 | $163,159 | 76,174 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-06 Option Award |
2025-03-10 4:44 pm |
N/A N/A |
VERACYTE INC. | VCYT | Wygant Jonathan VP, Chief Accounting Officer |
13,288 | $0 | 49,763 (Direct) |
View |
| 2025-03-06 Option Award |
2025-03-10 4:44 pm |
N/A N/A |
VERACYTE INC. | VCYT | Febbo Phillip G. Chief Scientific & Med Officer |
24,160 | $0 | 106,700 (Direct) |
View |
| 2025-03-06 Option Award |
2025-03-10 4:44 pm |
N/A N/A |
VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer |
30,200 | $0 | 143,899 (Direct) |
View |
| 2025-03-06 Option Award |
2025-03-10 4:43 pm |
N/A N/A |
VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA |
36,240 | $0 | 100,249 (Direct) |
View |
| 2025-03-06 Option Award |
2025-03-10 4:43 pm |
N/A N/A |
VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel |
30,200 | $0 | 100,508 (Direct) |
View |
| 2025-03-06 Option Award |
2025-03-10 4:43 pm |
N/A N/A |
VERACYTE INC. | VCYT | Stapley Marc Chief Executive Officer |
90,601 | $0 | 358,636 (Direct) |
View |
| 2025-03-02 Tax Withholding |
2025-03-03 4:30 pm |
N/A N/A |
VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA |
7,650 | $34.76 | 71,420 (Direct) |
View |
| 2025-02-27 Option Award |
2025-03-03 4:30 pm |
N/A N/A |
VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA |
11,006 | $0 | 71,420 (Direct) |
View |
| 2025-03-02 Tax Withholding |
2025-03-03 4:30 pm |
N/A N/A |
VERACYTE INC. | VCYT | Stapley Marc Chief Executive Officer |
20,324 | $34.76 | 320,732 (Direct) |
View |
| 2025-02-27 Option Award |
2025-03-03 4:30 pm |
N/A N/A |
VERACYTE INC. | VCYT | Stapley Marc Chief Executive Officer |
67,277 | $0 | 320,732 (Direct) |
View |
| 2025-02-27 Tax Withholding |
2025-03-03 4:30 pm |
N/A N/A |
VERACYTE INC. | VCYT | Stapley Marc Chief Executive Officer |
34,273 | $33.84 | 320,732 (Direct) |
View |
| 2025-03-02 Tax Withholding |
2025-03-03 4:30 pm |
N/A N/A |
VERACYTE INC. | VCYT | Febbo Phillip G. Chief Scientific & Med Officer |
6,754 | $34.76 | 90,577 (Direct) |
View |
| 2025-02-27 Option Award |
2025-03-03 4:30 pm |
N/A N/A |
VERACYTE INC. | VCYT | Febbo Phillip G. Chief Scientific & Med Officer |
30,589 | $0 | 90,577 (Direct) |
View |
| 2025-02-27 Tax Withholding |
2025-03-03 4:30 pm |
N/A N/A |
VERACYTE INC. | VCYT | Febbo Phillip G. Chief Scientific & Med Officer |
15,672 | $33.84 | 90,577 (Direct) |
View |
| 2025-03-02 Tax Withholding |
2025-03-03 4:30 pm |
N/A N/A |
VERACYTE INC. | VCYT | Wygant Jonathan VP, Chief Accounting Officer |
4,301 | $34.76 | 36,475 (Direct) |
View |
| 2025-03-02 Tax Withholding |
2025-03-03 4:30 pm |
N/A N/A |
VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer |
11,070 | $34.76 | 113,699 (Direct) |
View |
| 2025-02-27 Option Award |
2025-03-03 4:30 pm |
N/A N/A |
VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer |
23,170 | $0 | 113,699 (Direct) |
View |
| 2025-02-27 Tax Withholding |
2025-03-03 4:30 pm |
N/A N/A |
VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer |
11,911 | $33.84 | 113,699 (Direct) |
View |
| 2025-03-02 Tax Withholding |
2025-03-03 4:29 pm |
N/A N/A |
VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel |
8,255 | $34.76 | 71,450 (Direct) |
View |
| 2025-02-27 Option Award |
2025-03-03 4:29 pm |
N/A N/A |
VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel |
13,466 | $0 | 71,450 (Direct) |
View |
| 2025-02-27 Tax Withholding |
2025-03-03 4:29 pm |
N/A N/A |
VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel |
7,000 | $33.84 | 71,450 (Direct) |
View |
| 2025-01-06 Exercise |
2025-01-08 4:47 pm |
N/A N/A |
VERACYTE INC. | VCYT | EPSTEIN ROBERT S Director |
20,000 | $8.04 | 64,598 (Direct) |
View |
| 2025-01-06 Exercise |
2025-01-08 4:47 pm |
N/A 2025-01-12 |
VERACYTE INC. | VCYT | EPSTEIN ROBERT S Director |
20,000 | $0 | 64,598 (Direct) |
View |
| 2025-01-02 Exercise |
2025-01-06 5:16 pm |
N/A N/A |
VERACYTE INC. | VCYT | EASTHAM KARIN Director |
10,000 | $5.28 | 18,497 (Direct) |
View |
| 2025-01-02 Exercise |
2025-01-06 5:16 pm |
N/A 2026-06-20 |
VERACYTE INC. | VCYT | EASTHAM KARIN Director |
10,000 | $0 | 18,497 (Direct) |
View |
| 2024-12-02 Tax Withholding |
2024-12-04 4:59 pm |
N/A N/A |
VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel |
1,918 | $44.12 | 91,568 (Direct) |
View |
| 2024-12-02 Tax Withholding |
2024-12-04 4:59 pm |
N/A N/A |
VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA |
1,314 | $44.12 | 73,810 (Direct) |
View |
| 2024-12-02 Tax Withholding |
2024-12-04 4:59 pm |
N/A N/A |
VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer |
3,464 | $44.12 | 114,037 (Direct) |
View |
| 2024-12-02 Tax Withholding |
2024-12-04 4:59 pm |
N/A N/A |
VERACYTE INC. | VCYT | Febbo Phillip G. Chief Scientific & Med Officer |
6,738 | $44.12 | 86,348 (Direct) |
View |
| 2024-12-02 Tax Withholding |
2024-12-04 4:59 pm |
N/A N/A |
VERACYTE INC. | VCYT | Wygant Jonathan VP, Chief Accounting Officer |
1,087 | $44.12 | 40,270 (Direct) |
View |
| 2024-12-02 Tax Withholding |
2024-12-04 4:58 pm |
N/A N/A |
VERACYTE INC. | VCYT | Stapley Marc Chief Executive Officer |
5,748 | $44.12 | 312,935 (Direct) |
View |
| 2024-11-12 Exercise |
2024-11-14 4:35 pm |
N/A N/A |
VERACYTE INC. | VCYT | EPSTEIN ROBERT S Director |
15,000 | $8.04 | 64,598 (Direct) |
View |
| 2024-11-12 Exercise |
2024-11-14 4:35 pm |
N/A 2025-01-12 |
VERACYTE INC. | VCYT | EPSTEIN ROBERT S Director |
15,000 | $0 | 64,598 (Direct) |
View |
| 2024-09-02 Tax Withholding |
2024-09-04 8:24 pm |
N/A N/A |
VERACYTE INC. | VCYT | Chambers Rebecca Chief Financial Officer |
3,464 | $31.55 | 139,776 (Direct) |
View |
| 2024-09-02 Tax Withholding |
2024-09-04 8:08 pm |
N/A N/A |
VERACYTE INC. | VCYT | McGuire Annie SVP, General Counsel |
1,920 | $31.55 | 93,486 (Direct) |
View |
| 2024-09-02 Tax Withholding |
2024-09-04 6:08 pm |
N/A N/A |
VERACYTE INC. | VCYT | Wygant Jonathan VP, Chief Accounting Officer |
1,087 | $31.55 | 47,345 (Direct) |
View |
| 2024-09-02 Tax Withholding |
2024-09-04 5:08 pm |
N/A N/A |
VERACYTE INC. | VCYT | Stapley Marc Chief Executive Officer |
5,748 | $31.55 | 318,683 (Direct) |
View |
| 2024-09-02 Tax Withholding |
2024-09-04 4:44 pm |
N/A N/A |
VERACYTE INC. | VCYT | Leite John Chief Commercial Officer-CLIA |
1,315 | $31.55 | 81,653 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-04 4:19 pm |
N/A N/A |
VERACYTE INC. | VCYT | Miller Thomas F. Director |
16,507 | $0 | 16,507 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-04 4:19 pm |
N/A N/A |
VERACYTE INC. | VCYT | Shafer David Brent Director |
16,507 | $0 | 16,507 (Direct) |
View |